chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw, SARS-CoV-2 test
Clinical narrative: Hypertension; Lightheadedness/ Dizziness; Chest pain; Ear/jaw pain (same side as injection); Ear/jaw pain (same side as injection); Neck pressure (same side as injection); Whole arm numbness and pain (same side as injection); Whole arm numbness and pain (same side as injection); Leg cramping (same side as injection); Fatigue; Chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7458) via an unspecified route of administration in the left arm on 03Aug2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Aug2021, the patient experienced hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 04Aug2021, 14Aug2021 and 18Aug2021, the patient underwent Biofire/covid test through nasal swab and the results were negative. The clinical outcome of the events hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Chills; Fever; Sore Arm; Arthralgia; Myalgia; This is a spontaneous report from a non-contactable consumer, the patient. An adult non-pregnant female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Aug2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19, diagnosed prior to the vaccination. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 03Aug2021, the patient experienced chills, fever, sore arm, arthralgia and myalgia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, sore arm, arthralgia and myalgia was resolved with sequelae on an unknown date in Aug2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the left arm on 23Aug2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not aware of having any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. On 25Aug2021 at 09:00, the patient experienced dizziness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event dizziness was resolved on 25Aug2021.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Nerve compression, Pain, Paraesthesia, Vascular compression
Clinical narrative: Transient quadrilateral space syndrome. Imaging features on MRI and accompanying pain and paresthesias correlate; Transient quadrilateral space syndrome. Imaging features on MRI and accompanying pain and paresthesias correlate; Transient quadrilateral space syndrome. Imaging features on MRI and accompanying pain and paresthesias correlate; Transient quadrilateral space syndrome. Imaging features on MRI and accompanying pain and paresthesias correlate; This is a spontaneous report from a non-contactable physician, the patient. An adult male patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an intramuscular route of administration in the left arm on 20Aug2021 at 16:15 as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 20Aug2021 at 19:30, the patient experienced transient quadrilateral space syndrome, imaging features on magnetic resonance imaging (MRI) and accompanying pain and paresthesias correlate. On the same day, the patient underwent MRI and the result correlate transient quadrilateral space syndrome. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events transient quadrilateral space syndrome, imaging features on MRI and accompanying pain and paresthesias correlate was resolved on an unknown date in Aug2021.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Fever; Pain at injection site; Chills; Joint pain; Muscle pain; Headache; Lightheaded; Tired; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Aug2021 at 17:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and experienced drug allergy and received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Aug2021 at 17:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. On 25Aug2021 at 02:00, the patient experienced fever, pain at injection site, chills, joint pain, muscle pain, headache, lightheaded and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, pain at injection site, chills, joint pain, muscle pain, headache, lightheaded and tired was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever; Pain at injection site; Chills; Joint pain; Muscle pain; Headache; Lightheaded; Tired; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Aug2021 at 17:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and experienced drug allergy and received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Aug2021 at 17:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. On 25Aug2021 at 02:00, the patient experienced fever, pain at injection site, chills, joint pain, muscle pain, headache, lightheaded and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, pain at injection site, chills, joint pain, muscle pain, headache, lightheaded and tired was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, Menstruation irregular
Clinical narrative: Menstrual period has been delayed; Menstrual period has been missed; This is a spontaneous report from a non-contactable consumer, the patient. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13May2021 (at the age of 12-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Jun2021 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took polymyxin (MANUFACTURER UNKNOWN) and experienced drug allergy. On an unknown date in 2021, the patient experienced menstrual period has been delayed/missed. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events menstrual period has been delayed/missed was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache, Pain in extremity
Clinical narrative: Severe right arm pain; severe headache; Shortness of breath/Unable to take a deep breath; chest tightness; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: WE0187) via an unspecified route of administration in the arm right on 24Aug2021 at 10:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The medical history included chronic sinusitis, seasonal allergies, mild asthma only when sick and kidney cyst bilateral. The patient's known allergies were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included vitamin d nos (VITAMIN D) and ascorbic acid (VITAMIN C), all for unknown indications from unknown dates and unknown if ongoing. On 24Aug2021 at 11:30, the patient experienced severe right arm pain, severe headache, shortness of breath and chest tightness and was unable to take a deep breath. The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe right arm pain, severe headache, shortness of breath, chest tightness and unable to take a deep breath were not resolved at the time of this report.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Panic attack, Parosmia
Clinical narrative: Smelling cigarette smoke randomly-parosmia; Slight trouble breathing, panic attack/anxiety from it; Slight trouble breathing, panic attack/anxiety from it; Slight trouble breathing, panic attack/anxiety from it; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraines and urine infection. Concomitant medications included unspecified antibiotic for urine infection from an unknown date and unknown if ongoing.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On an unknown date in 2021, the patient experienced smelling cigarette smoke randomly-parosmia, slight trouble breathing, panic attack/anxiety from it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events smelling cigarette smoke randomly-parosmia, slight trouble breathing, panic attack/anxiety from it was not resolved at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue
Clinical narrative: Chest pain; Fatigue; Shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 04Jun2021 at 18:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 11May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 11Jun2021, the patient experienced chest pain, fatigue and shortness of breath. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain, fatigue and shortness of breath was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Confusional state, Diarrhoea, Myalgia, Pyrexia
Clinical narrative: Memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years); Memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years); Significant and pronounced joint & muscle pain; Significant and pronounced joint & muscle pain; Diarrhea; Slight fever; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 23Aug2021 at 18:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 24Aug2021 at 01:00 the patient experienced memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years), significant and pronounced joint & muscle pain, diarrhea and slight fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years), significant and pronounced joint & muscle pain, diarrhea and slight fever were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Retrograde amnesia
Clinical narrative: Memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years); Memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years); Significant and pronounced joint & muscle pain; Significant and pronounced joint & muscle pain; Diarrhea; Slight fever; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 23Aug2021 at 18:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 24Aug2021 at 01:00 the patient experienced memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years), significant and pronounced joint & muscle pain, diarrhea and slight fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events memory loss & confusion (forgot door code and could not remember how to process work transactions, after doing them for several years), significant and pronounced joint & muscle pain, diarrhea and slight fever were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face, Throat irritation, Urticaria
Clinical narrative: my face, particularly the right side, started itching; Breaking out in welts on my face; Over the next hour, my throat got itchy; right side of my face swelled; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the right arm on 03Mar2021 at 13:00 (at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history included allergic reaction to melon. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and tocopherol (VITAMIN E); all for unspecified indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 22Jan2021 at 14:00 (at the age of 43-year-old), as a single dose for COVID-19 immunisation.  On 05Mar2021 at 07:30, the patient was driving home from PT (working out) in the morning, and patient's face particularly the right side started itching and breaking out in welts on face. Over the next hour, throat got itchy and the right side of face was swelled. The patient went to the clinic and they told the patient to take Benadryl. The patient took 2 benadryl, and the swelling went down after several hours. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with diphenhydramine hydrochloride (BENADRYL) from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events face particularly the right side started itching and breaking out in welts on face. Over the next hour throat got itchy and the right side of face was swelled was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Erythema, Swelling
Clinical narrative: Large swelling under left arm in the pit area; A large swelling under my left arm in the pit area. Extending down towards my left breast; Extending down towards my left breast with redness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 57-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Aug2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included ropinirole hydrochloride (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Aug2021 at 00:00, in addition to the common symptoms listed for most people, the patient had a large swelling under her left arm in the pit area extending down towards her left breast with redness, which was a lot. The events did not result in doctor/other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events large swelling under left arm in the pit area, swelling extending down towards left breast with redness was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Vaccination site pain
Clinical narrative: Sore injection site; Fatigue; Tightness in chest; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 18:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date in Aug2021 at 03:00, the patient experienced sore injection site, fatigue and tightness in chest. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore injection site, fatigue and tightness in chest were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node swelling 2 days after first vaccine in neck same side as vaccine was given.; This is a spontaneous report from a non-contactable nurse, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Aug2021 at 15:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism on an unknown date and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC) for unknown indications, from unknown start dates and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Aug2021, 2 days after the first vaccine, the patient experienced lymph node swelling in neck on the same side as vaccine was given. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event lymph node swelling in neck on the same side as vaccine was given was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Migraine
Clinical narrative: Migraine; Dizziness; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 26Aug2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included gluten allergy, hypothyroid, adrenal insufficiency and wheat allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN) both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 05Aug2021 at 12:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 27Aug2021 at 04:00, the patient experienced migraine, dizziness and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, dizziness and joint pain were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hormone level abnormal
Clinical narrative: Feeling faint and dizzy off and on; Prolonged hormone disruption (symptoms similar to PCOS& thyroid disorders); probable link to cystgrowth; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Mar2021 (at the age of 20-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included multivitamin (vitamins C, D, B, E, etc.) (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient felt faint and dizzy off and on and had prolonged hormone disruption, the symptoms were similar to polycystic ovary syndrome (PCOS) and thyroid disorders; and a probable link to cyst growth. The events resulted in doctor/other health care professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling faint and dizzy off and on and prolonged hormone disruption were unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Asthenia, Pain
Clinical narrative: Joints pain; Body aches; No energy; Taste loss; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 17Aug2021 at 13:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol (NYQUIL) and guaifenesin (MUCINEX) and experienced drug allergy. On 18Aug2021 at 02:00, the patient experienced joints pain, body aches, no energy and taste loss. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joints pain, body aches, no energy and taste loss were resolving with sequelae on an unknown date in Aug2021.   No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Genital rash, Sensitive skin
Clinical narrative: Sensitive skin; Rash on left side of penis; This is a spontaneous report from a contactable pharmacist. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 26Aug2021 at 17:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Aug2021 at 17:00 the patient experienced rash on left side of penis and sensitive skin. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken or not as a result of the event. The clinical outcome of the events sensitive skin and rash on left side of penis was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypoaesthesia, Paraesthesia
Clinical narrative: Started sweating within 5 minutes of receiving my first shot of Covid vaccine; There was also numbness and tingling in left shoulder, left arm and hand. In a few minutes, right shoulder, arm and hand also had numbness and tingling. It started in both feet after a few hours; There was also numbness and tingling in left shoulder, left arm and hand. In a few minutes, right shoulder, arm and hand also had numbness and tingling. It started in both feet after a few hours/There is numbness in head too sometimes; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Aug2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD) on an unknown date and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Aug2021, the patient started sweating within 5 minutes of receiving the first shot of COVID-19 vaccine. There was also numbness and tingling in left shoulder, left arm and hand. The numbness started in both feet after a few hours. There was numbness in head too sometimes, especially if the patient rested her head on hand and lied down. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events and included treatment with paracetamol (TYLENOL) from an unknown date in Aug2021. The clinical outcome of the events sweating within 5 minutes of receiving first shot of COVID vaccine, numbness and tingling in left shoulder, left arm and hand, right shoulder, arm and hand also had numbness and tingling and in both feet after a few hours and numbness in head too sometimes was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node left arm; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Aug2021 at 14:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. On 26Aug2021 at 14:00, the patient experienced swollen lymph node left arm. The event swollen lymph node left arm did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node left arm was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: New onset left sided tinnitus; This is a spontaneous report from a non-contactable physician. A 53-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced new onset left sided tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event new onset left sided tinnitus was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: Eye lid swelling; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 06Aug2021 at 12:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 08Aug2021 at 09:00, the patient experienced eye lid swelling. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event eye lid swelling was resolving at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 27Aug2021 at 15:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue, Swelling, Vaccination site pain
Clinical narrative: Just over 48 hours after vaccination left armpit areaswollen; Just over 48 hours after vaccination left armpit areaswollen and slightly tender; Chills; Tiredness that lasted approximately 12 hours beginning approximately 15 hours after vaccination; Soreness at injection site still present 61 hours after vaccination.; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PC3182) via an unspecified route of administration in the left arm on 27Aug2021 at 17:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 06Aug2021 at 09:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient previously received ciprofloxacin (CIPRO) on unknown date for unspecified indication and experienced drug allergy. On 27Aug2021 at 20:00. the patient experienced soreness at injection site which was still present 61 hours after vaccination. On 28Aug2021, beginning approximately 15 hours after vaccination, the patient experienced chills and tiredness that lasted approximately 12 hours. On 29Aug2021, just over 48 hours after vaccination, the patient experienced left armpit area swollen and slightly tender. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events chills and tiredness was resolved on an unknown date in Aug2021, whereas the outcome for the events soreness at injection site which was still present 61 hours after vaccination, left armpit area swollen and slightly tender was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swelling in my face; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date the patient experienced swelling in face. The clinical outcome of the event "swelling in my face" was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Headache since 8/20; Nausea started this week; Vomiting started today; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the right arm on 19Aug2021 at 07:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, subarachnoid hemorrhage and brain bleed in 2 places. The patient had unspecified allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had received unspecified allergy injections (MANUFACTURER UNKNOWN) from 16Aug2021 within four weeks prior to the vaccination. Concomitant medications included topiramate (TOPAMAX), omeprazole (PRILOSEC) and sitagliptin phosphate (JANUVIA), all from an unknown date for an unknown indication. On 20Aug2021, the patient experienced headache since 8/20, nausea started this week (as reported) and vomiting started today (as reported). The patient thought the headache was normal because of her history. The patient had a history of migraines and subarachnoid hemorrhage, brain bleed in 2 places. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea and vomiting started today was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Maternal exposure during pregnancy, Pain in extremity
Clinical narrative: Sore arm; Headache; Fatigue; Pregnancy at the time of vaccination: Yes; Vaccine administration date: 26Aug2021 at 09:00; Last menstrual date: 03Jan2021; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old 33 weeks-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Aug2021 at 09:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The last menstrual date of the patient was on 03Jan2021. The delivery date of the patient was reported as 14Oct2021. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was reported that the patient received other vaccines within four weeks, prior to the COVID-19 vaccine and concomitant vaccines included tetanus vaccine toxoid, diphtheria vaccine toxoid, pertussis vaccine acellular (TDAP) on 11Aug2021. The patient previously received codeine (MANUFACTURER UNKNOWN) for an unknown indication and experienced drug allergy. On 26Aug2021 at 18:00, the patient had sore arm, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, headache and fatigue was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.